Participants 575 648 3
compare the pharmacokinetic (PK) parameters of two BDDrFVIII formulations
Participants 800 860 4
FVIII preparation (Hemofil M) in patients with haemophilia A
Participants 898 1020 4
A series of blood samples were collected over a period of 48 h after i.v. administration of each of the FVIII preparations
